Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: J Thromb Thrombolysis. 2015 Aug;40(2):161–166. doi: 10.1007/s11239-014-1155-5

Table 4.

Clinical characteristics of patients omitted from original trial

Clinical finding Placebo
Tenecteplase
N =4 N= 3
Obese (BMI>30 kg/m2) 3 75 % 1 33 %
Active malignancy 0 0 % 0 0 %
Prior history of PE or DVT 0 0 % 1 33 %
Chronic obstructive pulmonary disease 0 0 % 0 0 %
Heart failure 1 25 % 0 0 %
Age (years, mean and SD) 54 (7) 71 (16)
Body mass index (kg/m2) 32 (6) 34 (13)

PE pulmonary embolism, DVT deep venous thrombosis, BMI body mass index, SD standard deviation